Review Study
    Pharmacognosy Reviews
    Vol. 10
    Issue 20
    2016
    pp. 143-146
    Open Access

    Is Myrtol® Standardized a New Alternative toward Antibiotics?

    Maria Paparoupa1,Adrian Gillissen1
    1Department of Pulmonary Diseases, Klinikum Kassel, University Hospital of Southampton, Mönchebergstrasse 41‑43, D‑35125 Kassel, GERMANY.
    Correspondence:

    *Maria Paparoupa

    Department of Pulmonary Diseases, Klinikum Kassel University Hospital of Southampton, Mönchebergstrasse 41‑43, D‑35125 Kassel, GERMANY.

    maria.paparoupa@yahoo.com

    Copyright:

    2016 Author(s)

    Check for updates
    Published:21/11/2016

    Abstract

    GeloMyrtol® and GeloMyrtol® forte, also known as Myrtol® standardized, is an herbal medical product (phytomedicine) obtained by a multistep distillation procedure from essential oils. The major biological marker of in vivo and ex vivo activity of Myrtol® standardized is the monoterpenes, d‑limonene, 1,8‑cineole, and alpha‑pinene. Myrtol® standardized is estimated to have antioxidative, anti‑inflammatory, and antibacterial potential while many studies confirmed its secretolytic and bronchospasmolytic effects. As such, the medication is proposed to be initiated in several acute and chronic infections of the upper and lower airway system as acute and chronic rhinosinusitis, acute and chronic bronchitis, and chronic obstructive pulmonary disease. This review intends to give an insight into several prescription indications of Myrtol® standardized, all involved mechanisms, and potential advantages toward antibiotic therapy, especially in cases when bacterial infection is uncertain.

    Share on Mobile

    Scan to access on mobile

    Keywords

    Antibiotics
    GeloMyrtol®
    GeloMyrtol® forte
    indications
    mechanisms
    Myrtol® standardized
    No content available

    Related Articles